Analystreport

Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $126.00 price target on the sto

Edwards Lifesciences Corporation  (EW) 
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com